The Problem
Modern life has outpaced
our biology.
By prioritizing economic velocity over human well-being, we have created a world of global tension where we are running faster than our nervous systems were designed to endure — leaving us materially ambitious but emotionally exhausted.
Pharmacology Falls Short
Severe cognitive side effects and dependency risk from long-term medication leave millions without a safe, sustainable solution.
Therapist Shortage
Critical nationwide shortages of licensed clinicians mean millions in need cannot access care. No staffing model bridges this gap.
No Active Device Exists
A clinical-grade, autonomous, non-pharmacological care-delivery system does not yet exist. Until now.
Why AI. Why Now.
The convergence that
changes everything.
Robotics precision. AI personalization. Real-time biofeedback. For the first time, these three forces have matured simultaneously — making autonomous therapeutic delivery not only possible, but inevitable.
ARHIMOTION exists at this intersection. We are building the infrastructure for a new category: Physical AI in mental health.
nVIDIAInceptionProgram
Robotics Precision
Algorithmically driven motion stimulates the brain's innate parasympathetic pathways — mechanically, reliably, every session.
AI Personalization
A closed-loop intelligence layer learns from every session, creating an evolving therapeutic profile unique to each individual.
Real-Time Biofeedback
Objective physiological data drives every decision — not self-reports, not assumptions. The body tells us the truth.
The ADAMA Platform
Your body is the data.
The platform responds.
ADAMA is not a device that delivers a preset treatment. It is a closed-loop system that listens, learns, and adapts — session after session, user after user.
Think of it as automated robotic surgery: the robotics provides the physical intervention, while the AI acts as the surgeon's brain.
The Mission
Therapy Democratization.
One therapist treats five patients a day. ADAMA doesn't sleep. By removing staffing constraints and geographic barriers, we make expert-grade therapeutic care accessible to everyone.
Clinical Validation
Hard proof, not surveys.
Investors · Partners · Clinicians
Ready to pioneer the future
of mental health?
We are building partnerships with clinical networks, health systems, and strategic investors.
The Science
The science of
vestibular calm.
Ancient mechanisms. Modern precision. ARHIMOTION bridges the primal neuroscience of rhythmic motion with cutting-edge AI to deliver measurable therapeutic outcomes.
Mechanism
Why rocking works.
The vestibular system — the brain's balance and motion-sensing network — projects directly to the limbic system and autonomic control centers. Rhythmic whole-body movement speaks to these pathways fluently, in a language your nervous system already understands.
"The mechanisms we activate are deeply rooted in our nature — much like the instinct to rock a crying baby to soothe them. These are primal, effective pathways that the human body already understands and trusts."
What we engage
Vestibular Nuclei
Multi-directional motion stimulates the vestibular nuclei, projecting directly to limbic and autonomic control networks.
Neural Synchronization
Rhythmic whole-body movement entrains spontaneous neural oscillations, enhancing slow-wave sleep architecture.
Vibration & Sound Layer
A dedicated vibration component alongside therapeutic sound, delivered via ARHIMOTION's proprietary custom protocol.
Neuroplasticity Support
Supporting endogenous brain-clearing mechanisms and up-regulating neuroplasticity biomarkers — under clinical validation.
A New Paradigm
The evolution of care.
Pharmacology
Dependency. Side effects. No personalization. A blunt instrument for a precise problem.
Digital Therapy
Self-reporting. Screen fatigue. Static content. Better — but still passive.
Physical AI
Active, closed-loop, embodied. The nervous system engaged directly. The future is physical.
Clinical Validation
Hard proof,
not surveys.
We track definitive, immutable biofeedback endpoints — moving beyond self-reported questionnaires into objective, reproducible science.
Objective Endpoints
What we measure.
Live HRV Telemetry
Real-time heart rate variability as a continuous window into autonomic nervous system state — not a snapshot, a stream.
Muscle Tension Mapping
Continuous monitoring of regional hypertonicity and muscle guarding patterns via our proprietary in-house sensing technology.
Sleep Actigraphy
Objective sleep architecture analysis — N2/N3 wave data, sleep onset latency, nightly awakenings — not self-reported quality.
Longitudinal Vitality Metrics
Long-horizon biological tracking that reveals therapeutic trajectory over weeks and months.
Clinical Partners
Where validation happens.
Ruppin Academic Center
Phase 1 Research PartnerElite specialized research division in clinical neuroscience. Collaborative protocol design and endpoint analysis for our initial cohort study.
Sderot Resilience Center
Phase 1 Clinical SiteProspective, open-label trials targeting acute stress, trauma, and complex PTSD populations. 30-participant cohort with escalating session protocols.
Trial Design
30 participants · Escalating sessions: 15 / 30 / 45 min · Full biofeedback endpoint evaluation · IRB protocol ready
Regulatory Roadmap
A rigorous path to market.
Clinical safety by design: programmatic emergency shutdowns · automated motor load-limiters · HIPAA-aligned encrypted data architecture
About ARHIMOTION
De-risked scientific
innovation.
A scientifically defensible, closed-loop, biofeedback-driven platform — backed by rigorous clinical validation. Built in Israel. Engineered for the world.
Our Origin
Born from urgency.
ARHIMOTION was founded by Emanuel Natanov after more than 15 years in high-tech. The realization was clear: technology is deployed almost exclusively to maximize productivity — and almost never to serve the human being behind it.
When October 7 happened, the company witnessed a nation in acute trauma facing a catastrophic shortage of therapists. The urgency became existential.
"We witnessed a nation in trauma facing a severe shortage of therapists — a gap our robotics were designed to fill."
The Team
Emanuel Natanov
Co-Founder & Chief Executive Officer
15+ years in high-tech leadership. Systems architect turned healthcare pioneer. Driving the clinical, commercial, and capital strategy of ARHIMOTION.
Stanislav Murzakhanov
Co-Founder & Chief Technology Officer
Deep technical lead overseeing ADAMA platform architecture, software systems, and the closed-loop AI stack.
Industry Backing
Backed by NVIDIA Inception.
ARHIMOTION is a proud member of the NVIDIA Inception Program — a global initiative designed to nurture cutting-edge AI startups with technology, expertise, and go-to-market support. This reflects our deep commitment to AI-first architecture.
Program
Member of the NVIDIA Inception AI Startup Program
Insights
Latest Thinking.
Perspectives on automation therapy, Physical AI, and the future of mental health.
In Loving Memory
Dr. Michael Murzakhanov
1954 – October 7, 2023
Dr. Michael Murzakhanov
About Michael
Michael Murzakhanov, a compassionate doctor, dedicated his life to his family and healing his patients.
On the morning of October 7th, 2023, upon hearing the sirens, he rushed to fulfill his sacred duty of saving lives. On the way, he was ambushed by militants and brutally murdered, despite the clearly visible "on-duty doctor" markings on his vehicle.
"He was an incredible family man who gave his whole soul to his family. The medical profession served as a mission and a huge responsibility to him."
Michael dedicated most of his life to medicine — as a paramedic, ambulance doctor, and later as a neurologist and anesthesiologist. In the mid-1990s, he was a leader in developing a new methodology for rehabilitating people with paralysis from injury or stroke. One of the key methods was nerve stimulation through oscillatory movements and excitation of nerve endings.
In the era of new technologies, he and a group of experts began developing an autonomous multifunctional medical device for clinical and home use. For several years, Michael was the project's chief medical advisor. On October 7th, the project was in the prototype stage — and all of Michael's ideas and amendments had been implemented.
His Legacy Lives On
Project Next October has decided to support the startup's implementation — thereby perpetuating the memory of Michael Murzakhanov. The ADAMA platform carries forward the scientific vision he devoted his final years to realizing: nerve stimulation through oscillatory motion as a pathway to healing.
Michael's Album
מילים לזכרו
אדם שחי לאהבה, ללמידה ולריפוי — ממשיך לנשום בתוך כל מה שאנחנו בונים.
He is survived by his wife Nina, their sons Stanislav, Sergey and Wasily,
and seven beloved grandchildren. Buried in Beersheba, Israel.
Get in Touch
Let's build the future
together.
For investors, clinical partners, health systems, and media enquiries.
Send us a message
Direct contact
General Enquiries
info@arhimotion.com
CEO & Investor Relations
emanueln@arhimotion.com
Headquarters
Israel
European Operations
Germany
We typically respond to investor and clinical partnership inquiries within 48 business hours.